Magrath George 4

What Happened

• Magrath George, CEO of Opus Genetics, sold 24,438 shares on 2026-03-16 at a weighted average price of $5.21 per share, generating approximately $127,327 in proceeds. The sale was automatic to satisfy tax withholding obligations tied to the vesting and settlement of a restricted stock unit (RSU) award and was not a discretionary trade by the CEO.

Key Details

• Transaction date: 2026-03-16; Form 4 filed: 2026-03-18.
• Transaction type/code: Sale (S); reason: tax withholding for RSU settlement (footnote F1).
• Price: Weighted average $5.21; shares sold in multiple transactions at prices ranging $5.21 to $5.215 (footnote F2).
• Total proceeds reported: ~$127,327.
• Shares owned after transaction: Not specified in the provided filing.
• Timeliness: Filed two days after the transaction; no late-filing flag indicated.

Context

• This was a routine tax-withholding sale related to RSU vesting (often coded F), which is administrative and does not necessarily reflect the insider's market view. The filer offered to provide a per-trade breakdown of the shares sold at each price within the reported range upon request.